Showing results (361-370 of 376) with videos related to

Sort By:
Pageof 38
Diabetes & Metabolism|April 13, 2016
Effect of insulin analogues on frequency of non-severe hypoglycaemia in patients with type 1 diabetes prone to severe hypoglycaemia: The HypoAna trialR M Agesen, P L Kristensen, H Beck-Nielsen, et al.
European Journal of Preventive Cardiology|March 8, 2013
A prediction of the renal and cardiovascular efficacy of aliskiren in ALTITUDE using short-term changes in multiple risk markersP A Smink, J Hoekman, D E Grobbee, et al.
Clinical Pharmacology and Therapeutics|September 27, 2013
The importance of short-term off-target effects in estimating the long-term renal and cardiovascular protection of angiotensin receptor blockersP A Smink, Y Miao, M J C Eijkemans, et al.
Diabetologia|April 26, 2011
Retinal function in relation to improved glycaemic control in type 1 diabetesS K Holfort, K Nørgaard, G R Jackson, et al.
Frontiers in Endocrinology|October 28, 2022
Advanced glycation end-products are associated with diabetic neuropathy in young adults with type 1 diabetesElaf Al-Saoudi, Marie M B Christensen, Peter Nawroth, et al.
Diabetologia|April 27, 2013
The methylglyoxal-derived AGE tetrahydropyrimidine is increased in plasma of individuals with type 1 diabetes mellitus and in atherosclerotic lesions and is associated with sVCAM-1M G A van Eupen, M T Schram, H M Colhoun, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|October 31, 2008
Increased urinary orosomucoid excretion: a proposed marker for inflammation and endothelial dysfunction in patients with type 2 diabetesM S Christiansen, K Iversen, C T Larsen, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|September 22, 2020
Irbesartan treatment does not influence plasma levels of the dicarbonyls methylglyoxal, glyoxal and 3-deoxyglucosone in participants with type 2 diabetes and microalbuminuria: An IRMA2 sub-studyM Piazza, N M J Hanssen, F Persson, et al.
Diabetologia|August 17, 2010
A polymorphism in the gene encoding carnosinase (CNDP1) as a predictor of mortality and progression from nephropathy to end-stage renal disease in type 1 diabetes mellitusA Alkhalaf, S J L Bakker, H J G Bilo, et al.
Diabetes, Obesity & Metabolism|October 30, 2015
Is a reduction in albuminuria associated with renal and cardiovascular protection? A post hoc analysis of the ALTITUDE trialH J L Heerspink, T Ninomiya, F Persson, et al.
Pageof 38